Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice

S. J. Simpson, P. Tomlinson, A. L. Mellor

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

CBA (H-2k) mice carrying a H-2Kb transgene (CD2Kb) linked to transcriptional control elements from the human CD2 gene express H-2Kb at high levels on all thymocytes and peripheral T cells. However, skin grafts from two independent transgenic lineages, CD2Kb-2 and CD2Kb-3, are not rejected by recipient CBA mice. Although mice from both lineages tolerate H-2Kb disparate skin grafts, tolerance is maintained by different mechanisms because H-2Kb-specific cytotoxic T cells cannot be generated in vitro using CD2Kb-2 responder spleen cells, but can be generated when responder cells are from CD2Kb-3 mice. Furthermore, H-2Kb-restricted cytotoxic T cell responses directed against minor histocompatlbillty antigens can be obtained from CD2Kb-2 responder mice. Thus, negative and positive selection of immature thymocytes seems to take place in CD2Kb-2 mice, even though the pattern of H-2Kb expression is modified by the CD2Kb transgene. In contrast, H-2Kb-specific cytotoxic T cell precursors are not eliminated in CD2Kb-3 mice, even though all thymocytes express H-2Kb in these mice. However, these potentially autoreactive H-2Kb-specific T cells are apparently inactive in vivo and fail to lyse syngeneic CD2Kb-3 target cells in vitro, even when activated to lyse other H-2Kb-expressing cells. These results reveal that tolerance in CD2Kb-3 mice is induced either by a non-deletional mechanism or by partial elimination of a subset of cytotoxlc T cell precursors capable of recognizing H-2Kb as a target antigen.

Original languageEnglish (US)
Pages (from-to)189-198
Number of pages10
JournalInternational Immunology
Volume5
Issue number2
DOIs
StatePublished - Feb 1 1993

Fingerprint

Transgenic Mice
T-Lymphocytes
Thymocytes
T-Lymphoid Precursor Cells
Transgenes
Transplantation Tolerance
Antigens
Inbred CBA Mouse
Skin
Spleen
Transplants
Genes

Keywords

  • Major histocompatibility complex
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice. / Simpson, S. J.; Tomlinson, P.; Mellor, A. L.

In: International Immunology, Vol. 5, No. 2, 01.02.1993, p. 189-198.

Research output: Contribution to journalArticle

Simpson, S. J. ; Tomlinson, P. ; Mellor, A. L. / Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice. In: International Immunology. 1993 ; Vol. 5, No. 2. pp. 189-198.
@article{3cfdf854e9534dabbb9a07d14ff98115,
title = "Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice",
abstract = "CBA (H-2k) mice carrying a H-2Kb transgene (CD2Kb) linked to transcriptional control elements from the human CD2 gene express H-2Kb at high levels on all thymocytes and peripheral T cells. However, skin grafts from two independent transgenic lineages, CD2Kb-2 and CD2Kb-3, are not rejected by recipient CBA mice. Although mice from both lineages tolerate H-2Kb disparate skin grafts, tolerance is maintained by different mechanisms because H-2Kb-specific cytotoxic T cells cannot be generated in vitro using CD2Kb-2 responder spleen cells, but can be generated when responder cells are from CD2Kb-3 mice. Furthermore, H-2Kb-restricted cytotoxic T cell responses directed against minor histocompatlbillty antigens can be obtained from CD2Kb-2 responder mice. Thus, negative and positive selection of immature thymocytes seems to take place in CD2Kb-2 mice, even though the pattern of H-2Kb expression is modified by the CD2Kb transgene. In contrast, H-2Kb-specific cytotoxic T cell precursors are not eliminated in CD2Kb-3 mice, even though all thymocytes express H-2Kb in these mice. However, these potentially autoreactive H-2Kb-specific T cells are apparently inactive in vivo and fail to lyse syngeneic CD2Kb-3 target cells in vitro, even when activated to lyse other H-2Kb-expressing cells. These results reveal that tolerance in CD2Kb-3 mice is induced either by a non-deletional mechanism or by partial elimination of a subset of cytotoxlc T cell precursors capable of recognizing H-2Kb as a target antigen.",
keywords = "Major histocompatibility complex, Tolerance",
author = "Simpson, {S. J.} and P. Tomlinson and Mellor, {A. L.}",
year = "1993",
month = "2",
day = "1",
doi = "10.1093/intimm/5.2.189",
language = "English (US)",
volume = "5",
pages = "189--198",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice

AU - Simpson, S. J.

AU - Tomlinson, P.

AU - Mellor, A. L.

PY - 1993/2/1

Y1 - 1993/2/1

N2 - CBA (H-2k) mice carrying a H-2Kb transgene (CD2Kb) linked to transcriptional control elements from the human CD2 gene express H-2Kb at high levels on all thymocytes and peripheral T cells. However, skin grafts from two independent transgenic lineages, CD2Kb-2 and CD2Kb-3, are not rejected by recipient CBA mice. Although mice from both lineages tolerate H-2Kb disparate skin grafts, tolerance is maintained by different mechanisms because H-2Kb-specific cytotoxic T cells cannot be generated in vitro using CD2Kb-2 responder spleen cells, but can be generated when responder cells are from CD2Kb-3 mice. Furthermore, H-2Kb-restricted cytotoxic T cell responses directed against minor histocompatlbillty antigens can be obtained from CD2Kb-2 responder mice. Thus, negative and positive selection of immature thymocytes seems to take place in CD2Kb-2 mice, even though the pattern of H-2Kb expression is modified by the CD2Kb transgene. In contrast, H-2Kb-specific cytotoxic T cell precursors are not eliminated in CD2Kb-3 mice, even though all thymocytes express H-2Kb in these mice. However, these potentially autoreactive H-2Kb-specific T cells are apparently inactive in vivo and fail to lyse syngeneic CD2Kb-3 target cells in vitro, even when activated to lyse other H-2Kb-expressing cells. These results reveal that tolerance in CD2Kb-3 mice is induced either by a non-deletional mechanism or by partial elimination of a subset of cytotoxlc T cell precursors capable of recognizing H-2Kb as a target antigen.

AB - CBA (H-2k) mice carrying a H-2Kb transgene (CD2Kb) linked to transcriptional control elements from the human CD2 gene express H-2Kb at high levels on all thymocytes and peripheral T cells. However, skin grafts from two independent transgenic lineages, CD2Kb-2 and CD2Kb-3, are not rejected by recipient CBA mice. Although mice from both lineages tolerate H-2Kb disparate skin grafts, tolerance is maintained by different mechanisms because H-2Kb-specific cytotoxic T cells cannot be generated in vitro using CD2Kb-2 responder spleen cells, but can be generated when responder cells are from CD2Kb-3 mice. Furthermore, H-2Kb-restricted cytotoxic T cell responses directed against minor histocompatlbillty antigens can be obtained from CD2Kb-2 responder mice. Thus, negative and positive selection of immature thymocytes seems to take place in CD2Kb-2 mice, even though the pattern of H-2Kb expression is modified by the CD2Kb transgene. In contrast, H-2Kb-specific cytotoxic T cell precursors are not eliminated in CD2Kb-3 mice, even though all thymocytes express H-2Kb in these mice. However, these potentially autoreactive H-2Kb-specific T cells are apparently inactive in vivo and fail to lyse syngeneic CD2Kb-3 target cells in vitro, even when activated to lyse other H-2Kb-expressing cells. These results reveal that tolerance in CD2Kb-3 mice is induced either by a non-deletional mechanism or by partial elimination of a subset of cytotoxlc T cell precursors capable of recognizing H-2Kb as a target antigen.

KW - Major histocompatibility complex

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0027459410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027459410&partnerID=8YFLogxK

U2 - 10.1093/intimm/5.2.189

DO - 10.1093/intimm/5.2.189

M3 - Article

C2 - 8095799

AN - SCOPUS:0027459410

VL - 5

SP - 189

EP - 198

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 2

ER -